Literature DB >> 16028843

The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas.

Alexandra Giatromanolaki1, Vasiliki Arvanitidou, Athanasios Hatzimichael, Constantinos Simopoulos, Efthimios Sivridis.   

Abstract

AIM: To investigate the pathogenesis of capillary haemangiomas, a common form of vascular malformation.
METHODS: Twenty-five cutaneous capillary haemangiomas, excised from patients under 14 years of age, were studied immunohistochemically for endothelial cells, the angiogenic factors thymidine phosphorylase (TP) and vascular endothelial growth factor (VEGF), the proliferation index Ki-67, and the hypoxia inducible factors-1alpha (HIF-1alpha) and -2alpha (HIF-2alpha).
RESULTS: Endothelial-lined channels reacted strongly with CD31 in all cases, clearly definining capillary spaces. Between 5 and 20% of the endothelial cells were Ki-67 positive, indicating an intense proliferative activity; more importantly, they consistently expressed VEGF and HIF-2alpha, and in many cases TP, but failed to react with HIF-1alpha.
CONCLUSION: It is suggested that the activation of the HIF-2alpha pathway and the consequent overexpression of VEGF by the endothelial cells are involved in the pathogenesis of cutaneous capillary haemangiomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16028843     DOI: 10.1080/00313020400025011

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  9 in total

Review 1.  Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-08-26       Impact factor: 3.183

2.  Snail1 mediates hypoxia-induced melanoma progression.

Authors:  Shujing Liu; Suresh M Kumar; James S Martin; Ruifeng Yang; Xiaowei Xu
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

3.  Treatment of hemangioma by transfection of antisense VEGF gene.

Authors:  Shengguo Shan; Guang Shan; Duanlian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

4.  Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma.

Authors:  Melissa Frei-Jones; Robert C McKinstry; Arie Perry; Jeffrey R Leonard; Tae Sung Park; Joshua B Rubin
Journal:  J Neurosurg Pediatr       Date:  2008-08       Impact factor: 2.375

5.  Oral propranolol for circumscribed choroidal hemangioma.

Authors:  Empar Sanz-Marco; Roberto Gallego; Manuel Diaz-Llopis
Journal:  Case Rep Ophthalmol       Date:  2011-02-25

Review 6.  Hypoxia-inducible factor as an angiogenic master switch.

Authors:  Takuya Hashimoto; Futoshi Shibasaki
Journal:  Front Pediatr       Date:  2015-04-24       Impact factor: 3.418

7.  Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation.

Authors:  Weili Yuan; Xukai Wang
Journal:  Biomed Res Int       Date:  2021-01-27       Impact factor: 3.411

8.  Chinese medicine, Gui Lu Er Xian Jiao - related serous retinal detachment 2nd to circumscribed choroidal hemangioma a case report.

Authors:  Hsin Hui Huang; Shiuh-Liang Hsu; Shwu-Jiuan Sheu
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-10

Review 9.  Circumscribed Choroidal Hemangioma.

Authors:  Saeed Karimi; Ramin Nourinia; Arman Mashayekhi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.